stoxline Quote Chart Rank Option Currency Glossary
  
Regencell Bioscience Holdings Limited (RGC)
29.12  1.87 (6.86%)    04-17 16:00
Open: 28.37
High: 29.4994
Volume: 18,751
  
Pre. Close: 27.25
Low: 27.0482
Market Cap: 379(M)
Technical analysis
2025-04-17 4:51:59 PM
Short term     
Mid term     
Targets 6-month :  54.04 1-year :  80.59
Resists First :  46.27 Second :  69
Pivot price 29.28
Supports First :  9.5 Second :  7.9
MAs MA(5) :  31.51 MA(20) :  32.75
MA(100) :  11.55 MA(250) :  8.25
MACD MACD :  2.8 Signal :  3.9
%K %D K(14,3) :  39.8 D(3) :  40.2
RSI RSI(14): 52.1
52-week High :  69 Low :  3.02
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ RGC ] has closed above bottom band by 48.7%. Bollinger Bands are 15% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 29.51 - 29.69 29.69 - 29.86
Low: 26.65 - 26.85 26.85 - 27.04
Close: 28.8 - 29.11 29.11 - 29.4
Company Description

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Headline News

Fri, 21 Mar 2025
Why Regencell Bioscience Holdings Ltd. (RGC) Surged On Thursday? - Yahoo Finance

Thu, 20 Mar 2025
10 Micro-, Small-Cap Firms Dominate Thursday’s Gains - Insider Monkey

Thu, 20 Mar 2025
Regencell stock soars to 52-week high, hits $45 amid staggering growth - Investing.com

Tue, 18 Mar 2025
Pre-market Movers: RGC, SYRS, ADTX, ATXI... - RTTNews

Mon, 17 Mar 2025
Why Regencell Bioscience Holdings Limited (RGC) Soared Last Week? - Yahoo Finance

Sat, 15 Mar 2025
Insiders of Regencell Bioscience Holdings Limited (NASDAQ:RGC) have had a great week after last week's US$111m gain and they haven't stopped buying - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 13 (M)
Shares Float 1 (M)
Held by Insiders 93.8 (%)
Held by Institutions 0.2 (%)
Shares Short 297 (K)
Shares Short P.Month 18 (K)
Stock Financials
EPS -0.34
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.62
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -28.2 %
Return on Equity (ttm) -43.2 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.35
Qtrly Earnings Growth 0 %
Operating Cash Flow -4 (M)
Levered Free Cash Flow -2 (M)
Stock Valuations
PE Ratio -88.25
PEG Ratio 0
Price to Book value 46.22
Price to Sales 0
Price to Cash Flow -94.72
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android